TriCelX Launches XytriX™ as Department of Defense Collaboration Under the Blast Overpressure Safety Act
Files First Cell Therapy IND in Chronic Traumatic Encephalopathy with Concurrent RMAT and Breakthrough Therapy Designation Requests FRISCO, TX, UNITED STATES, May 26, 2026 /EINPresswire.com/ -- TriCelX, Inc., a vertically integrated clinical- …